Singapore, Singapore

Sylvie Claudette Alonso

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Institut Pasteur De Lille, National Institute of Health and Medical Research, National University of Singapore. Active years: 2016-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sylvie Claudette Alonso. Retrieved from https://idiyas.com/inventor/sylvie-claudette-alonso

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Sylvie Claudette Alonso: Innovator in Vaccine Development

Introduction

Sylvie Claudette Alonso is a prominent inventor based in Singapore, known for her significant contributions to vaccine development. With a total of five patents to her name, she has made remarkable strides in the field of immunology.

Latest Patents

One of her latest patents focuses on the prevention of pertussis using adenylate cyclase deficient Bordetella strains. A CyaA-deficient mutant was constructed and utilized in a vaccine. The pertussis-specific antibody profile and Th17 response induced by vaccination with the mutant was surprisingly comparable to that induced by strains not deficient in CyaA. This innovative approach highlights her commitment to advancing vaccine efficacy.

Career Highlights

Throughout her career, Sylvie has worked with esteemed institutions such as the National University of Singapore and the Institut National de la Santé et de la Recherche Médicale. Her work has been pivotal in enhancing our understanding of vaccine mechanisms and their applications.

Collaborations

Sylvie has collaborated with notable colleagues, including Camille Locht and Rui Fen Annabelle Lim. These partnerships have further enriched her research and contributed to her success in the field.

Conclusion

Sylvie Claudette Alonso's innovative work in vaccine development exemplifies her dedication to improving public health through scientific research. Her contributions continue to influence the field of immunology and vaccine technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…